Product Details for ANDA 090237
OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)
5MG
Marketing Status: Discontinued
20MG
Marketing Status: Discontinued
40MG
Marketing Status: Discontinued
5MG
Marketing Status: Discontinued
Active Ingredient: OLMESARTAN MEDOXOMIL
Proprietary Name: OLMESARTAN MEDOXOMIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090237
Product Number: 001
Approval Date: Apr 13, 2020
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information
OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)
Proprietary Name: OLMESARTAN MEDOXOMIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090237
Product Number: 001
Approval Date: Apr 13, 2020
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information
20MG
Marketing Status: Discontinued
Active Ingredient: OLMESARTAN MEDOXOMIL
Proprietary Name: OLMESARTAN MEDOXOMIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090237
Product Number: 002
Approval Date: Apr 13, 2020
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information
OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL)
Proprietary Name: OLMESARTAN MEDOXOMIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 20MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090237
Product Number: 002
Approval Date: Apr 13, 2020
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information
40MG
Marketing Status: Discontinued
Active Ingredient: OLMESARTAN MEDOXOMIL
Proprietary Name: OLMESARTAN MEDOXOMIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090237
Product Number: 003
Approval Date: Apr 13, 2020
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: OLMESARTAN MEDOXOMIL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 40MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A090237
Product Number: 003
Approval Date: Apr 13, 2020
Applicant Holder Full Name: SANDOZ INC
Marketing Status: Discontinued
Patent and Exclusivity Information